Fenbendazole and mebendazole are both benzimidazole anthelmintic (dewormer) drugs, but the primary difference is that mebendazole is FDA-approved for human use, while fenbendazole is approved only for veterinary use.

Feature Mebendazole Fenbendazole Approved Use Human parasitic worm infections (e.g., pinworms, roundworms, whipworms). Animal parasitic worm infections (dogs, cats, livestock, etc.). FDA Status FDA-approved for human use. Not approved for human use.

Prescription Status Requires a prescription for human use. Available over-the-counter in veterinary formulations.

Safety Profile Well-established human safety profile from decades of use. Human safety and appropriate dosage are not well-documented in medical literature.

Cancer Research Has been studied in human clinical trials for potential cancer treatment (off-label use only). Only has lab/animal data and anecdotal reports; no published human clinical trials for cancer. Bioavailability Offers better absorption in the human body compared to fenbendazole. Poor water solubility and absorption limit its effectiveness in the human body.

Key Distinction The most critical difference is that mebendazole has an established guidance for human safety and dosing, setting it apart from fenbendazole, which is limited to veterinary medicine.

Both drugs are being investigated for potential anti-cancer properties in preclinical studies, but due to its established safety profile and better bioavailability in humans, mebendazole is the one currently in human clinical trials.